logo
Plus   Neg
Share
Email

Lululemon Athletica Confident In Long-term China Growth Amid Coronavirus Impact

Athletic apparel company lululemon athletica inc. (LULU) Friday said it remains confident in the long-term opportunities in China, despite the current disruption to its growing business in the region due to the coronavirus outbreak.

In the update on the outbreak, the company said it continues to work closely with local authorities to prioritize the safety of its people and guests in the region.

The majority of lululemon's 38 stores in China have been closed since February 3, while some are now operating on a reduced schedule. The company's online business has continued to operate.

Calvin McDonald, Chief Executive Officer, said, "We're inspired by the resilience and commitment of our team in China as we navigate the emerging impacts of the coronavirus. The safety of our people is our highest priority, and we are adjusting store operations based upon the recommendations of local authorities."

The company said it continues to monitor the situation and will provide an update on the financial and operational impact on its fourth quarter fiscal 2019 earnings call, to be held in late March.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
McDonald's Corp. is delaying the reopening of all dine-in services in its U.S. restaurants by 21 days due to the increase in coronavirus cases across the country, reports said citing an internal letter. The burger chain said, "Our resiliency will be tested again. COVID-19 cases are on the rise." The U.S. Department of Health and Human Services or HHS said it has secured most of the supply of COVID-19 drug remdesivir through September. The deal would allow American hospitals to purchase the antiviral drug in allocated amounts amid the spike in confirmed cases each day. HHS Secretary Alex Azar said, "President Trump has struck an amazing deal to ensure Americans have access to the first..." Novartis AG (NVS) agreed to pay $678 million to settle U.S. government charges it paid illegal kickbacks to doctors to induce them to prescribe its cardiovascular and diabetes drugs, the U.S. Department of Justice said in a statement.
Follow RTT